Log In
Print
BCIQ
Print
Print this Print this
 

Emulsified Influenza HA Vaccine

Also known as: Cell culture-based pandemic influenza vaccine

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionCell culture-based pandemic influenza vaccine developed using EB66 cell line
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine: Cellular vaccine
Latest Stage of DevelopmentApproved
Standard IndicationInfluenza virus
Indication DetailsVaccinate against pandemic influenza virus infection
Regulatory Designation

Japan - Orphan Drug (Vaccinate against pandemic influenza virus infection);
Japan - Standard Review (Vaccinate against pandemic influenza virus infection)

Partner

Kaketsuken


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today